New Treatment for Lung Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment for multifocal lung adenocarcinoma?
The research highlights that multifocal lung adenocarcinoma is a unique type of lung cancer with a slower progression and less likelihood of spreading compared to other types. This suggests that treatments targeting its specific characteristics may be effective, although direct evidence for the new treatment's effectiveness is not provided.12345
What safety data exists for the new lung cancer treatment?
What makes the new treatment for multifocal lung adenocarcinoma unique?
The new treatment for multifocal lung adenocarcinoma is unique because it may involve targeted therapy based on specific genetic mutations, such as the KIAA1468-RET fusion gene, which can be identified through advanced genetic testing. This approach allows for personalized treatment strategies that are more effective for individual patients compared to standard therapies.123911
What is the purpose of this trial?
To gather preliminary safety and outcome data for the multimodality treatment of lung adenocarcinoma in the setting of multifocal BAC.
Research Team
Dennis A. Wigle
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for adults over 18 with multifocal lung adenocarcinoma, no distant metastases, and capable lungs for surgery. It's not for pregnant women or those who've had other cancers (except certain early-stage ones), prior chest radiation, chemotherapy, or lung cancer surgery.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive multimodality treatment including aggressive local and targeted systemic therapy, informed by tumor genome sequencing
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pulmonary function testing and survival assessments
Treatment Details
Interventions
- Multifocal Lung Adenocarcinoma
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor